Estradiol cypionate/hydroxyprogesterone caproate

Estradiol cypionate /
hydroxyprogesterone caproate
	Estradiol cypionate (top) and; hydroxyprogesterone caproate (bottom)
Combination of
Estradiol cypionate	Estrogen
Hydroxyprogesterone caproate	Progestogen
Clinical data
Trade names	Sinbios
Other names	EC/OHPC
Routes of; administration	Intramuscular injection

Estradiol cypionate/hydroxyprogesterone caproate (EC/OHPC), sold under the brand name Sinbios, is a combination medication of estradiol cypionate (EC), an estrogen, and hydroxyprogesterone caproate (OHPC), a progestin, which was reportedly used as a combined injectable contraceptive in women in the early 1970s.^[1] It contained 5 mg EC and 250 mg OHPC in oil solution, was provided in the form of 1 mL ampoules, and was administered by intramuscular injection at regular intervals.^[1] The medication was manufactured by the pharmaceutical company Mavi in Mexico.^[1]

References

^ ^a ^b ^c Rudel HW, Kinel FA (September 1972). "Oral Contraceptives. Human Fertility Studies and Side Effects". In Tausk M (ed.). Pharmacology of the Endocrine System and Related Drugs: Progesterone, Progestational Drugs and Antifertility Agents. Vol. II. Pergamon Press. pp. 385–469. ISBN 978-0080168128. OCLC 278011135.

This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.